Latest raise
$8M
Date raised
October 8, 2026
Round
Series A
InvestorsDynagrow Capital, LLLP
Websitevincipharmaceuticals.com
About Karl Csaky
Vinci Pharmaceuticals is disrupting retinal disease treatment with EPIPLANT™, a proprietary needle free drug delivery platform.
- Who is Karl Csaky?
- Karl Csaky is listed as Co-founder of Vinci Pharmaceuticals, a biotechnology company.
- How much did Vinci Pharmaceuticals raise?
- Vinci Pharmaceuticals raised $8M in a Series A round on October 8, 2026 (25 days ago). Backed by Dynagrow Capital, LLLP.
Get newly funded founders every week
A free weekly list of startups that just raised.